Out of the total number, 17 studies, including 8638 subjects, explored the association between COMT genotype polymorphism and neurological and psychiatric disorders, and nine studies were drug-based or pharmacogenetic studies that included a total of 5115 subjects. The gene discussed is COMT; the disease is psychiatric disorder.